NAD advises USPLabs to tone down advertising claims supporting AP supplement
NEW YORK — The National Advertising Division earlier this week recommended that USPLabs discontinue claims referencing “clinical” or “university” studies for the company’s AP Dietary Supplement. NAD further recommended that the advertiser modify the claim “Award Winning Nutrient Partitioning Agent” to disclose that the designation was awarded by “Planet Muscle Magazine” in 2008, 2009 and 2010.
NAD noted in its decision that the advertiser voluntarily agreed to add language to future advertisements to clarify that the supplement does not serve to “block” carb or render them indigestible. To avoid potential consumer confusion, NAD recommended the advertiser modify the advertising to note that the supplement “may help” or is “designed to help” the body “better use” carbohydrates.
In its advertiser’s statement, the company said it would take NAD’s recommendations into account in future advertising “with the goal of always producing accurate and substantiated [advertisements].”
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.
CHPA’s Stop Medicine Abuse campaign named honoree for the 17th Annual Webby Awards
WASHINGTON — The Consumer Healthcare Products Association’s Stop Medicine Abuse campaign was selected as an official honoree in the 17th Annual Webby Awards in the Family/Parenting category, the over-the-counter association announced Thursday.
“We are very excited to receive this recognition, as our call to action has always been reaching parents about a problem that often flies under the radar screen and mobilizing them to safeguard their medicines cabinets and talk to their teens,” stated Emily Skor, CHPA VP communications and alliance development. “It’s encouraging to be named among many well-known groups as we continue to seek innovative ways to give parents the tools and information they need to prevent cough medicine abuse and keep their teens safe.”
Launched in 2009, StopMedicineAbuse.org was redesigned last year to provide parents and community leaders with new tools and information to engage them in the fight against teen abuse of OTC cough medicine containing dextromethorphan. One in 20 teens reports abusing OTC cough medicine to get high, CHPA noted. The Stop Medicine Abuse campaign has an active presence on Facebook, Twitter and YouTube, providing parents with prevention tips and generating parent-to-parent conversations led by five moms from across the United States with different backgrounds who make up the Stop Medicine Abuse Five Moms team.
The Webby Awards is the leading international award honoring excellence on the Internet. The Webbys is presented by the International Academy of Digital Arts and Sciences, a 1,000+ member judging body that includes executive members comprised of leading web experts, business figures, luminaries, visionaries and creative celebrities.
Abbott Diabetes Care recalls FreeStyle lnsulinx Blood Glucose Meters
ALAMEDA, Calif. — Abbott Diabetes Care earlier this week initiated a voluntary recall of its FreeStyle lnsulinx Blood Glucose Meters in the United States.
"Our first priority is to safeguard the health and safety of patients," stated Heather Mason, SVP Diabetes Care, Abbott. "We are committed to ensuring that our customers are able to continue to test their blood glucose with confidence, and we initiated this voluntary recall to ensure our products continue to meet the highest standards of quality and safety."
The company has determined that at extremely high blood glucose levels of 1024 mg/dL and above, the FreeStyle lnsulinx Meter will display and store in memory an incorrect test result that is 1024 mg/dL below the measured result. For example, at a blood glucose value of 1066 mg/dL, the meter will display and store a value of 42 mg/dL.
No other Abbott blood glucose meters are impacted by this issue.
Blood glucose levels at 1024 mg/dL and above are very rare. However, if high blood glucose levels of 1024 mg/dL and above do occur, they are a serious health risk and require immediate medical attention. As the FreeStyle lnsulinx Meter can display an inaccurate low result at a blood glucose level above 1024 mg/dL, there may be a delay in the identification and treatment of severe hyperglycemia, or incorrect treatment may be given, the company noted.
The company is notifying all registered users, healthcare professionals, pharmacies and distributors where the FreeStyle lnsulinx Meter is sold. Abbott estimates that there are approximately 50,000 active FreeStyle lnsulinx Meter users in the United States.
Are you a nurse practitioner or physician’s assistant? Join our Facebook group to get all the latest news dedicated to delivering healthcare services to patients in retail pharmacy clinics.